5JS-50420-89781

Timeline

1. 2023-01-25
   Registered in v-safe
2. 2023-01-25
   Dose 1 — Pfizer-BioNTech

   Co-administered: Flu
3. 2023-01-25
   Health check-in — day 0, dose 1, under 3

   Feeling: Good · None

   Under 3 check-in
4. 2023-01-27
   Health check-in — days 1–6 daily, dose 1, under 3

   Feeling: Good · None

   Under 3 check-in
5. 2023-01-28
   Survey response — days 1–6 daily, dose 1, under 3

   MedDRA: Diarrhoea — Feeling: Good

   MedDRA releases: 2024-11
6. 2023-01-29
   Health check-in — days 1–6 daily, dose 1, under 3

   Feeling: Good · None

   Under 3 check-in
7. 2023-01-30
   Health check-in — days 1–6 daily, dose 1, under 3

   Feeling: Good · None

   Under 3 check-in
8. 2023-01-31
   Health check-in — days 1–6 daily, dose 1, under 3

   Feeling: Good · None

   Under 3 check-in
9. 2023-02-01
   Health check-in — day 7, dose 1, under 3

   Feeling: Good · None

   Under 3 check-in
10. 2023-02-08
    Survey response — day 14, dose 1, under 3

    MedDRA: Cough, Diarrhoea, Pyrexia, Sputum discoloured — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

    MedDRA releases: 2024-11
11. 2023-02-08
    Report sent to call center — day 14, dose 1, under 3

    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

    Outpatient clinic or urgent care clinic visit · 1 call case(s)
12. 2023-02-09
    Call successful

    Participant prefers to complete VAERS report online
13. 2023-02-15
    Health check-in — day 21, dose 1, under 3

    Feeling: Good

    Under 3 check-in
14. 2023-02-22
    Dose 2 — Pfizer-BioNTech
15. 2023-02-22
    Health check-in — day 0, dose 2, under 3

    Feeling: Good · None

    Under 3 check-in
16. 2023-02-22
    Survey response — day 28, dose 1, under 3

    MedDRA: Decreased appetite, Diarrhoea, Vomiting — Feeling: Fair · Be unable to work or attend school

    MedDRA releases: 2024-11
17. 2023-02-23
    Health check-in — days 1–6 daily, dose 2, under 3

    Feeling: Good · None

    Under 3 check-in
18. 2023-02-24
    Health check-in — days 1–6 daily, dose 2, under 3

    Feeling: Fair · Sleepiness, Irritability/crying, Diarrhea · Be unable to do your normal daily activities

    Under 3 check-in
19. 2023-02-28
    Survey response — days 1–6 daily, dose 2, under 3

    MedDRA: Cough — Feeling: Fair

    MedDRA releases: 2024-11
20. 2023-03-10
    Survey response — day 14, dose 2, under 3

    MedDRA: Dermatitis diaper — Feeling: Good

    MedDRA releases: 2024-11
21. 2023-03-15
    Survey response — day 21, dose 2, under 3

    MedDRA: Cough, Pyrexia — Feeling: Fair · Be unable to work or attend school

    MedDRA releases: 2024-11
22. 2023-03-24
    Survey response — day 28, dose 2, under 3

    MedDRA: Croup infectious — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

    MedDRA releases: 2024-11
23. 2023-03-24
    Report sent to call center — day 28, dose 2, under 3

    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

    Outpatient clinic or urgent care clinic visit · 1 call case(s)
24. 2023-03-27
    Call 1 — Left Voicemail
25. 2023-03-27
    Callback requested for

    03:00PM ET
26. 2023-03-27
    Call successful

    Does not wish to fill out VAERS report
27. 2023-04-05
    Health check-in — day 42, dose 2, under 3

    Feeling: Good

    Under 3 check-in